Biotech Knockoffs Lure Novartis

Biotech Knockoffs Lure Novartis
“A big pharma player is expanding its generics business. Expect others to follow
The divide between those making brand-name drugs and those producing generics is about to become a bit less clear. “

Click here for reuse options!
Copyright 2004 Biotechblog

Leave a Reply

%d bloggers like this: